ArticleEuropean journal of pediatrics2025
Optical coherence tomography and angiography reveal early retinal alterations in pediatric-onset multiple sclerosis.
Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Retinal proteomics in neurodegeneration: Insights into ocular and brain disorders.Neural regeneration research · 2026Article
- Nucleus-specific thalamic volumes and retinal thickness in pediatric-onset multiple sclerosis: a cross-sectional study.European journal of pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this study is to investigate alterations in optical coherence tomography (OCT) and OCT angiography (OCT-A) parameters in patients with pediatric-onset multiple sclerosis (POMS). This prospective cross-sectional study included 37 POMS patients and 36 healthy controls (HCs). We performed OCT and OCT-A scans. POMS eyes were categorized into two subgroups: those with a history of optic neuritis (MS + ON) and those without (MS-ON). The mean ages of the POMS patients and HCs were 15.8 ± 0.2 and 14.7 ± 2.5 years, respectively (p = 0.266). Compared with that in HCs, the retinal nerve fiber layer (RNFL) thickness in MS + ON eyes was lower in three segments; it was significantly lower only in the temporal segment in MS-ON eyes. In all quadrants, except one, ganglion cell-inner plexiform layer (GC-IPL) thicknesses were significantly thinner in MS + ON and MS-ON eyes than in HCs. In multiple quadrants, vessel density (VD) in the radial peripapillary capillary (RPC) plexus was significantly lower in MS + ON eyes than in MS-ON and HCs. Compared with those of MS-ON and HCs, the whole and perifoveal VDs in the superficial capillary plexus (SCP) of MS + ON eyes were significantly lower. VD in the deep capillary plexus (DCP) and foveal avascular zone (FAZ) did not differ between groups.
conclusionThe OCT-A findings in POMS patients include a reduction in vessel density in the macula and peripapillary area in the setting of optic neuritis. The thinning of the GC-IPL and RNFL was observed in POMS eyes irrespective of prior ON history, but ON was associated with more prominent thinning. WHAT IS KNOWN: • On the basis of the reported clinical association between the MS course and retinal dysfunction, quantitative retinal vessel measurements may be potential markers for MS. • The literature shows that the majority of OCT and OCT-A studies were in adult MS patients, with a limited number of studies in children. WHAT IS NEW: • In this study, we present 37 POMS patients, identify clinically silent retinal nerve fiber and ganglion cell loss independent of optic neuritis, and demonstrate a reduction in vessel density in the macula and peripapillary area in the setting of optic neuritis. • The inclusion of very early cases of MS, such as the pediatric group, may offer a unique opportunity to better understand the impact of retinal vascular changes on disease pathogenesis.
Indexed as
Identifiers
40478274What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.